ANTIGENS & ANTIBODIES FOR COMMERCIAL IMMUNOASSAY DEVELOPMENT. Tropical and vector-borne diseases account for more than 17% of all infectious diseases, causing more than 1 million deaths annually. Recognizing infected patients early in their clinical course is critical to preventing outbreaks. Meridian offers a range of antigens and antibodies suitable for the development of sensitive and specific immunoassays that detect tropical and vector-borne diseases.
Page 1 Page 2 Page 3 Page 4